Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease

Mattia Bellan, Pier Paolo Sainaghi, Margherita Tran Minh, Rosalba Minisini, Luca Molinari, Marco Baldrighi, Livia Salmi, Matteo Nazzareno Barbaglia, Luigi Mario Castello, Paolo Ravanini, Gian Carlo Avanzi, Mario Pirisi

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Aim: Plasma Gas6 was tested as an alternative to Baveno VI criteria (liver stiffness <20 kPa and platelet count >150 × 109/l) in an endoscopy-sparing strategy. Methods: A total of 160 patients with chronic hepatitis C and advanced fibrosis/cirrhosis underwent, on the same occasion, liver elastography, upper endoscopy, a platelet count and serum Gas6 measurement. Results: A total of 74/160 (46%) patients had esophageal varices, that were small (diameter <5 mm) in 57/160 (34%) and large in 17/160 (11%) cases. A total of 34/160 (21%) patients satisfied Baveno VI criteria, according to which screening for esophageal varices could have been omitted; 1/34 had large varices (sensitivity 94%). A plasma Gas6 value <45 ng/ml, detected in 34/160 (21%) patients, was also 94% sensitive. Conclusion: Plasma Gas6 might represent a feasible alternative to Baveno VI criteria when transient elastography is unavailable/unsuccessful.

Lingua originaleInglese
pagine (da-a)27-34
Numero di pagine8
RivistaBiomarkers in Medicine
Volume12
Numero di pubblicazione1
DOI
Stato di pubblicazionePubblicato - gen 2018

Fingerprint

Entra nei temi di ricerca di 'Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease'. Insieme formano una fingerprint unica.

Cita questo